Cited by 614Genetic Associations and EpidemiologySmoking Behavior and CessationGenetic Mapping and Diversity in Plants and Animals

Meta-analysis and imputation refines the association of 15q25 with smoking quantity

Open access
The Wellcome Trust Case Control Consortium, Liu, Jason Z, Tozzi, Federica, Waterworth, Dawn M, Pillai, Sreekumar G, Muglia, Pierandrea, Middleton, Lefkos, Berrettini, Wade +99 more·2010·Nature Genetics

Abstract

Smoking is a leading global cause of disease and mortality. We established the Oxford-GlaxoSmithKline study (Ox-GSK) to perform a genome-wide meta-analysis of SNP association with smoking-related behavioral traits. Our final data set included 41,150 individuals drawn from 20 disease, population and control cohorts. Our analysis confirmed an effect on smoking quantity at a locus on 15q25 (P = 9.45 x 10(-19)) that includes CHRNA5, CHRNA3 and CHRNB4, three genes encoding neuronal nicotinic acetylcholine receptor subunits. We used data from the 1000 Genomes project to investigate the region using imputation, which allowed for analysis of virtually all common SNPs in the region and offered a fivefold increase in marker density over HapMap2 (ref. 2) as an imputation reference panel. Our fine-mapping approach identified a SNP showing the highest significance, rs55853698, located within the promoter region of CHRNA5. Conditional analysis also identified a secondary locus (rs6495308) in CHRNA3.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.572

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The strongest finding for smoking behavior is an association of smoking quantity with a cluster of nicotinic receptor genes (CHRNA5-CHRNA3-CHRNB4) with an effect size corresponding to one cigarette per day.

    “The strongest finding is an association of smoking quantity with a cluster of nicotinic receptor genes (CHRNA5-CHRNA3-CHRNB4) with an effect size corresponding to one cigarette per day, and there may be several independent associations. 104”
  • There may be several independent associations to the nicotinic receptor gene cluster for smoking quantity.

    “The strongest finding is an association of smoking quantity with a cluster of nicotinic receptor genes (CHRNA5-CHRNA3-CHRNB4) with an effect size corresponding to one cigarette per day, and there may be several independent associations. 104”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
The Wellcome Trust Case Control Consortium, Liu, J. Z., Tozzi, F., Waterworth, D. M., Pillai, S. G., Muglia, P., Middleton, L., Berrettini, W., Knouff, C. W., Yuan, X., Waeber, G., Vollenweider, P., Preisig, M., Wareham, N. J., Zhao, J. H., Loos, R. J. F., Barroso, I., Khaw, K.-T., Grundy, S., Barter, P., Mahley, R., Kesaniemi, A., McPherson, R., Vincent, J. B., Strauss, J., Kennedy, J. L., Farmer, A., McGuffin, P., Day, R., Matthews, K., Bakke, P., Gulsvik, A., Lucae, S., Ising, M., Brueckl, T., Horstmann, S., Wichmann, H.-E., Rawal, R., Dahmen, N., Lamina, C., Polasek, O., Zgaga, L., Huffman, J., Campbell, S., Kooner, J., Chambers, J. C., Burnett, M. S., Devaney, J. M., Pichard, A. D., Kent, K. M., Satler, L., Lindsay, J. M., Waksman, R., Epstein, S., Wilson, J. F., Wild, S. H., Campbell, H., Vitart, V., Reilly, M. P., Li, M., Qu, L., Wilensky, R., Matthai, W., Hakonarson, H. H., Rader, D. J., Franke, A., Wittig, M., Schäfer, A., Uda, M., Terracciano, A., Xiao, X., Busonero, F., Scheet, P., Schlessinger, D., Clair, D. S., Rujescu, D., Abecasis, G. R., Grabe, H. J., Teumer, A., Völzke, H., Petersmann, A., John, U., Rudan, I., Hayward, C., Wright, A. F., Kolcic, I., Wright, B. J., Thompson, J. R., Balmforth, A. J., Hall, A. S., Samani, N. J., Anderson, C. A., Ahmad, T., Mathew, C. G., Parkes, M., Satsangi, J., Caulfield, M., Munroe, P. B., Farrall, M., Dominiczak, A., Worthington, J., Thomson, W., Eyre, S., Barton, A., Mooser, V., Francks, C., & Marchini, J.
Affiliations
  • University of Oxford (GB)
  • GlaxoSmithKline (Italy) (IT)
  • GlaxoSmithKline (United States) (US)
  • Imperial College London (GB)
  • University of Pennsylvania (US)
  • University of Lausanne (CH)
  • University of Cambridge (GB)
  • Wellcome Sanger Institute (GB)
  • The University of Texas Southwestern Medical Center (US)
  • The Heart Research Institute (AU)
  • University of California, San Francisco (US)
  • Ottawa Heart Institute (CA)
  • Centre for Addiction and Mental Health (CA)
  • King's College London (GB)
  • University of Dundee (GB)
  • University of Bergen (NO)
  • Max Planck Institute of Psychiatry (DE)
  • Helmholtz Munich (DE)
  • Johannes Gutenberg University Mainz (DE)
  • Innsbruck Medical University (AT)
  • University of Edinburgh (GB)
  • Institute of Genetics and Cancer (GB)
  • MedStar Washington Hospital Center (US)
  • Children's Hospital of Philadelphia (US)
  • Christian-Albrechts-Universität zu Kiel (DE)
  • Institute of Genetic and Biomedical Research (IT)
  • National Institute on Aging (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • University of Aberdeen (GB)
  • Ludwig-Maximilians-Universität München (DE)
  • University of Michigan (US)
  • Universität Greifswald (DE)
  • Universitätsmedizin Greifswald (DE)
  • University of Split (HR)
  • University of Leicester (GB)
  • University of Leeds (GB)
  • Peninsula College of Medicine and Dentistry (GB)
  • Guy's Hospital (GB)
  • Addenbrooke's Hospital (GB)
  • Western General Hospital (GB)
  • Queen Mary University of London (GB)
  • Centre for Human Genetics (GB)
  • Western Infirmary (GB)
  • University of Manchester (GB)
Corresponding author
  • Francks, Clyde
  • Marchini, Jonathan
Venue
Nature Genetics
Published
2010-04-25
Volume
42
Issue
5
Pages
436-440
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2122791877
Cited by
614
References
39
Citations by year
2026: 4 · 2025: 11 · 2024: 11 · 2023: 15 · 2022: 21 · 2021: 30 · 2020: 23 · 2019: 29 · 2018: 44 · 2017: 40 · 2016: 59 · 2015: 64 · 2014: 59 · 2013: 47 · 2012: 72
FWCI
6.88
Type
journal article
Language
en
Open access
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • IRIS (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Leicester Research Archive (University of Leicester) (submittedVersion)
  • Site cant be reached (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Funders
  • GlaxoSmithKline
  • University of Oxford
  • National Institutes of Health (Z99 AG999999, 5t32ag000196-20)
  • National Institute on Aging (T32-AG000196, R99 AG999999, ZIAAG000196, Z01AG000196)
  • National Institute on Drug Abuse (R01DA025201)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
Keywords
smoking quantity, CHRNA5, CHRNA3, CHRNB4, neuronal nicotinic acetylcholine receptors, fine mapping, genetic association, imputation, promoter
MeSH terms
Adult, Aged, Alleles, Chromosome Mapping, Chromosomes, Human, Pair 15, Female, Genetic Markers, Humans, Male, Middle Aged, Models, Genetic, Neurons, Receptors, Nicotinic, Smoking, Cohort Studies, Genome, Human, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review